CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
OSL:CONTX - Euronext Oslo - SE0014731154 - Common Stock - Currency: NOK
Taking everything into account, CONTX scores 7 out of 10 in our fundamental rating. CONTX was compared to 12 industry peers in the Health Care Technology industry. CONTX gets an excellent profitability rating and is at the same time showing great financial health properties. CONTX has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year CONTX was profitable.
In the past year CONTX had a positive cash flow from operations.
CONTX had positive earnings in 4 of the past 5 years.
In the past 5 years CONTX always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 18.94%, CONTX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CONTX's Return On Equity of 26.18% is amongst the best of the industry. CONTX outperforms 91.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 23.10%, CONTX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CONTX is significantly above the industry average of 9.17%.
The last Return On Invested Capital (23.10%) for CONTX is well below the 3 year average (36.72%), which needs to be investigated, but indicates that CONTX had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.94% | ||
| ROE | 26.18% | ||
| ROIC | 23.1% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
CONTX's Profit Margin of 18.89% is amongst the best of the industry. CONTX outperforms 83.33% of its industry peers.
CONTX's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 22.81%, CONTX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CONTX has grown nicely.
The Gross Margin of CONTX (97.44%) is better than 91.67% of its industry peers.
In the last couple of years the Gross Margin of CONTX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.81% | ||
| PM (TTM) | 18.89% | ||
| GM | 97.44% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
CONTX has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CONTX remains at a similar level compared to 5 years ago.
The debt/assets ratio for CONTX is higher compared to a year ago.
2.2 Solvency
CONTX has a debt to FCF ratio of 0.36. This is a very positive value and a sign of high solvency as it would only need 0.36 years to pay back of all of its debts.
The Debt to FCF ratio of CONTX (0.36) is better than 91.67% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that CONTX is not too dependend on debt financing.
CONTX has a Debt to Equity ratio of 0.08. This is amongst the best in the industry. CONTX outperforms 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.36 | ||
| Altman-Z | N/A |
ROIC/WACC3.23
WACC7.15%
2.3 Liquidity
CONTX has a Current Ratio of 3.81. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
CONTX's Current ratio of 3.81 is amongst the best of the industry. CONTX outperforms 100.00% of its industry peers.
CONTX has a Quick Ratio of 3.78. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CONTX (3.78) is better than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.81 | ||
| Quick Ratio | 3.78 |
3. Growth
3.1 Past
CONTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.85%.
Measured over the past years, CONTX shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.26% on average per year.
The Revenue has decreased by -1.04% in the past year.
The Revenue has been growing slightly by 6.51% on average over the past years.
EPS 1Y (TTM)-24.85%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%85.65%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%2.82%
3.2 Future
The Earnings Per Share is expected to grow by 21.49% on average over the next years. This is a very strong growth
CONTX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.99% yearly.
EPS Next Y41.38%
EPS Next 2Y24.57%
EPS Next 3Y21.49%
EPS Next 5YN/A
Revenue Next Year7.03%
Revenue Next 2Y6.07%
Revenue Next 3Y7.04%
Revenue Next 5Y5.99%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 17.79, which indicates a rather expensive current valuation of CONTX.
Compared to the rest of the industry, the Price/Earnings ratio of CONTX indicates a rather cheap valuation: CONTX is cheaper than 83.33% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CONTX to the average of the S&P500 Index (28.10), we can say CONTX is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 13.29, the valuation of CONTX can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CONTX indicates a somewhat cheap valuation: CONTX is cheaper than 75.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.74. CONTX is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.79 | ||
| Fwd PE | 13.29 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CONTX is on the same level as its industry peers.
75.00% of the companies in the same industry are more expensive than CONTX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.83 | ||
| EV/EBITDA | 9.36 |
4.3 Compensation for Growth
CONTX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CONTX has an outstanding profitability rating, which may justify a higher PE ratio.
CONTX's earnings are expected to grow with 21.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.43
PEG (5Y)0.65
EPS Next 2Y24.57%
EPS Next 3Y21.49%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.03, CONTX pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.43, CONTX pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y24.57%
EPS Next 3Y21.49%
OSL:CONTX (5/6/2025, 12:03:23 PM)
6.049
+0.15 (+2.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners15.98%
Inst Owner ChangeN/A
Ins Owners25.32%
Ins Owner ChangeN/A
Market Cap468.01M
Analysts84.44
Price Target7.14 (18.04%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)46.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.79 | ||
| Fwd PE | 13.29 | ||
| P/S | 3.32 | ||
| P/FCF | 14.83 | ||
| P/OCF | 13.18 | ||
| P/B | 4.61 | ||
| P/tB | 4.79 | ||
| EV/EBITDA | 9.36 |
EPS(TTM)0.34
EY5.62%
EPS(NY)0.46
Fwd EY7.53%
FCF(TTM)0.41
FCFY6.75%
OCF(TTM)0.46
OCFY7.59%
SpS1.82
BVpS1.31
TBVpS1.26
PEG (NY)0.43
PEG (5Y)0.65
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.94% | ||
| ROE | 26.18% | ||
| ROCE | 29.24% | ||
| ROIC | 23.1% | ||
| ROICexc | 85.43% | ||
| ROICexgc | 98.28% | ||
| OM | 22.81% | ||
| PM (TTM) | 18.89% | ||
| GM | 97.44% | ||
| FCFM | 22.41% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexcg growth 3Y-39.35%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.36 | ||
| Debt/EBITDA | 0.19 | ||
| Cap/Depr | 42.29% | ||
| Cap/Sales | 2.79% | ||
| Interest Coverage | 146.11 | ||
| Cash Conversion | 85.68% | ||
| Profit Quality | 118.66% | ||
| Current Ratio | 3.81 | ||
| Quick Ratio | 3.78 | ||
| Altman-Z | N/A |
F-Score5
WACC7.15%
ROIC/WACC3.23
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.85%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%85.65%
EPS Next Y41.38%
EPS Next 2Y24.57%
EPS Next 3Y21.49%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%2.82%
Revenue Next Year7.03%
Revenue Next 2Y6.07%
Revenue Next 3Y7.04%
Revenue Next 5Y5.99%
EBIT growth 1Y-25.55%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year71.07%
EBIT Next 3Y27.47%
EBIT Next 5YN/A
FCF growth 1Y-24.42%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-26.4%
OCF growth 3Y51.49%
OCF growth 5Y5.6%